Last edition
News about "Summit Therapeutics"
AstraZeneca and Summit Therapeutics Partner on ADC Cancer Strategy
AstraZeneca has announced strategic equity investment and clinical collaboration with Summit Therapeutics to advance leading ADC combination strategy in cancer.
Summit Therapeutics | 01/10/2026 | By News Bureau
Ivonescimab Plus Chemotherapy Approved in China for First-Line Squamous NSCLC
Ivonescimab plus chemotherapy has been approved in China for first-line squamous NSCLC, based on the HARMONi-6 Phase 3 trial and significant overall survival benefit.
Summit Therapeutics | 13/08/2026 | By News Bureau | 199
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy